Our study first identified the pro-oncogenic role of FSTL1 in cSCC and revealed a novel mechanism, THOC7-AS1/OCT1/FSTL1, regulating EMT and promoting tumor progression, demonstrating significant innovation. This evidence concerns the gene THOC7 and neoplasm.